Posted on 11 月 10, 202011/10/20
Managing Risks to Improve Health Outcomes: How to Move Population Health Forward in an Era of Uncertainty
Posted on 11 月 5, 202011/5/20
Do Germany’s New Hemophilia Regulations Have Wider-Reaching Implications?
Posted on 10 月 14, 202010/14/20
Italy Tackles HTA, Pricing and Reimbursement Reforms
Posted on 9 月 25, 20209/25/20
Trends in HTA Decisions
Posted on 9 月 21, 20209/21/20
Navigate the Complexity of Proposed CMS Medicaid Rule
Posted on 9 月 14, 20209/14/20
At the COVID-19 Finish Line, How Do We Price The Winning Vaccine?
Posted on 9 月 11, 20209/11/20
How to Get Your Digital Therapeutic Approved & Reimbursed in Europe and the U.S.
Posted on 9 月 2, 20209/2/20
CMS Announces Medicare Coverage for FDA-Designated Breakthrough Devices. What Does This Mean?
Posted on 7 月 16, 20207/16/20
CMS Proposed Medicaid Rule: Best Price Impacts of Value-Based Purchasing, Co-Pay Assistance Programs, and More
Posted on 7 月 15, 20207/15/20